Parameter Identifiability beyond the Fisher Information Approximation in Data-Driven Modeling

Introduction to the show: ident: Genomics Radio. Generated commentary on the latest computational biology and genomics papers.

Ines: Today's paper: "Parameter Identifiability beyond the Fisher Information Approximation in Data-Driven Modeling".

Marcus: The gist The paper presents a computational framework that uncovers fundamental scaling laws governing practical identifiability and uncertainty quantification in data-driven biological modeling,

Ines: First, who's behind it and why it matters.

Paper summary: Ines: So we're talking about this paper now. It's called "Parameter Identifiability beyond the Fisher Information Approximation in Data-Driven Modeling." Marcus and I think it tackles a big problem in making sense of complex biological data.

Marcus: Exactly. The core idea here is that when you try to use data-driven models for things like HIV dynamics or Alzheimer's disease, you need to know if the parameters you estimate are actually stable or if your model can even recover them reliably.

Ines: Right, so they're moving beyond just using the Fisher Information Matrix, which is often a rough approximation. They want a way to rigorously check parameter identifiability under data perturbations while keeping track of the full Hessian matrix.

Marcus: That sounds like they're trying to fix that issue where traditional methods might miss directions where the model is poorly constrained, or where the likelihood profile is flat.

Ines: Their main contribution seems to be a new metric, K i, which quantifies parameter identifiability at different orders. They have this zero-order component, K zero which recovers the traditional parameter identifiability we already know.

Marcus: And they also introduce the first-order metric, K one which specifically captures when you see flat likelihood profiles when that zero-order component is zero <ref:2602.20495#pg1>. That's where things get tricky for people trying to fit parameters with weak constraints.

Ines: It seems like this is crucial because traditional profile likelihood methods often fail when the profiles are numerically insensitive, and this framework aims to resolve those parameters.

Marcus: It’s important because it gives us a way to see exactly which parameters are resolvable at different scales of complexity in the model. They use an eigenvalue decomposition with the Schur complement to classify identifiability across these hierarchical scales.

Ines: So, what does this mean practically for our work? We're looking at HIV signaling, and this framework helps us understand where the parameter uncertainty is coming from—is it just noise, or is it because of these non-identifiable subspaces?

Marcus: And they don't stop there. They build a robust uncertainty quantification protocol that explicitly accounts for higher-order practically nonidentifiable parameters. They separate the contribution from zero-order and first-order nonidentifiability into different regions in the parameter space, red and blue regions.

Ines: That hierarchical containment principle where higher-order uncertainty manifolds are nested within their zero-order counterparts is pretty powerful for understanding how errors propagate through these models.

Marcus: When they look at the HIV host-virus dynamics model, they found that some eigen-coordinates show zero-order practical identifiability, while others display first-order practical identifiability. That's a specific scaling law in action.

Ines: And when we look at amyloid- beta accumulation in the brain, they see similar patterns with higher-order practical identifiability appearing in the carrying capacity parameters across different cortical regions. It’s consistent across these very different biological systems.

Marcus: The paper shows that zero-order non-identifiability influences both the initial HIV outbreak and later phases of viral relapse, while first-order non-identifiability mainly modulates those early stages of infection. That's a specific way the uncertainty scales with time or infection progression.

Ines: So, it’s about providing a diagnostic tool to ensure that when we build these large-scale mechanistic digital twins, we know exactly where our data inferences are grounded and where the model is pushing us toward uncertainty.

Marcus: It really provides a concrete way to move past just relying on Fisher information when dealing with high-dimensional data. The scaling laws they uncover suggest a fundamental structure to parameter resolvability that we can use across many fields.

Ines: So, what's the conclusion of this paper? In short, it lays out this novel framework for analyzing higher-order parameter identifiability analysis based on scaling laws governing parameter resolvability.

Marcus: And it grounds all of this in a computational approach that is applicable to many high-dimensional biological models. It’s about ensuring our data-driven inferences are robust by understanding these scaling laws governing how parameters can actually be resolved.

Ines: It seems like the authors are providing a necessary structure for translating complex, large-scale mechanistic digital twins into something that is actionable and biologically meaningful.

Marcus: That's what it boils down to. They give us a way to quantify uncertainty arising from non-identifiable subspaces across different orders, which helps us manage those risks in our models.

Conclusion: Ines: So we’ve been deep into how they use this new metric K i to check if a parameter is really identifiable in these big biological models, and now we need to wrap up what all this actually means.

Marcus: Yeah, the paper title itself, "Parameter Identifiability beyond the Fisher Information Approximation," it’s pretty direct about what they’re trying to fix—moving past just using that standard Fisher Information Matrix.

Ines: Right. It says they're looking at how parameters are stable even when you mess with the data a little bit, and they do this while keeping track of the whole Hessian matrix instead of just discarding it.

Marcus: And I think that’s where it gets interesting for us in genomics data science—we want to know if our estimates hold up under noise or batch effects, and this method gives us a way to measure that stability directly.

Ines: They introduce these scaling laws, so the paper shows you a hierarchy of how resolvable parameters are, which isn't just one single number but a whole structure across the parameter space.

Marcus: It’s not just about whether we can find all the parameters, it's about *how* difficult it is to find them at different levels of complexity in the model itself.

Ines: And when you look at HIV dynamics or amyloid-beta accumulation, they show these patterns—some parameters are identifiable at the first order, others only after a second order correction.

Marcus: That’s where I get excited about the implications for cohort studies; if we can map out where those non-identifiable directions are, we know exactly what kind of data perturbation would cause us to lose track of our estimates.

Ines: So the authors are giving us a way to diagnose which parts of the biological system we need to worry about most when building these large-scale digital twins.

Marcus: And they also show how uncertainty itself scales, separating the uncertainty coming from zero-order versus first-order nonidentifiable parameters. It’s a systematic way to quantify that risk in our predictions.

Ines: So, the main point is that this framework moves us past simple approximations and gives us a more rigorous tool for checking if our data-driven biology makes sense on a larger scale.

Marcus: Exactly. And it sets up the next step for figuring out how to build those robust digital twins we talked about earlier.